Mounjaro 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5ZLB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,465
Award facts
- Contract value 100% obligated
- $30,465.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $30,465.45 for Mounjaro 5 mg/0.5 ml pen injections on December 10, 2025, with a completion date of December 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a tirzepatide-based pharmaceutical used for diabetes management, consistent with AmerisourceBergen's established role as a primary pharmaceutical supplier to federal military and veteran healthcare systems.
This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion vehicle extending through December 2026 that serves as a comprehensive global pharmaceutical support platform. The IDC enables AmerisourceBergen to supply an extensive range of pharmaceutical products, specialty medications, vaccines, and medical supplies to support military healthcare programs and other federal agencies including the Defense Health Agency and U.S. Coast Guard. The DLA's Pharmaceutical Prime Vendor Global Program Generation V strategy anticipates multiple regional awards among several contractors, positioning AmerisourceBergen as one of several key pharmaceutical vendors supporting federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F5ZLB?
SPE2DR26F5ZLB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26F5ZLB worth?
The government has obligated $30,465 on SPE2DR26F5ZLB.
Is contract SPE2DR26F5ZLB an order under another contract?
Yes. SPE2DR26F5ZLB is a delivery order under SPE2DR25D2109, an indefinite delivery contract.
Was contract SPE2DR26F5ZLB competed?
The extent of competition for SPE2DR26F5ZLB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award